Literature DB >> 3538365

Plasma and urinary C-peptide in the classification of adult diabetics.

P Koskinen, J Viikari, K Irjala, H L Kaihola, P Seppälä.   

Abstract

Plasma and urinary C-peptide determinations in the discrimination between insulin-requiring and non-insulin-requiring diabetes were elevated in 61 adult diabetics. Specimens for C-peptide determinations were taken on two consecutive days: on the first day plasma C-peptide concentrations were determined before and 6 min after intravenous glucagon administration. On the second day 2- and 4-h urinary C-peptide excretion was measured after an individual breakfast. Results of urinary C-peptide analyses were expressed as molar concentration and also as molar quantity excreted (without any corrections and related to creatinine excretion). Glucagon-stimulated plasma C-peptide turned out to be a reliable criterion for the detection of insulin requirement. Sixty-nine per cent of diabetics included in this study were classifiable by basal plasma C-peptide concentrations. Two-hour postprandial urinary C-peptide/creatinine quotient turned out to be slightly less sensitive (89%) than the glucagon test (94%) and of equal specificity (96%). Glucagon-stimulated plasma C-peptide and postprandial urinary C-peptide excretion correlated significantly among insulin-requiring diabetics (r = 0.73), but not among non-insulin-requiring diabetics (r = 0.23). We regard determination of stimulated plasma C-peptide as a primary investigation for the direct assessment of endogenous insulin secretory reserves for clinical management decisions. Determination of postprandial urinary C-peptide is applicable in selected situations for non-invasive assessment of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3538365     DOI: 10.3109/00365518609083728

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  9 in total

1.  The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.

Authors:  H J Gjessing; B Reinholdt; O Pedersen
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

2.  The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non insulin-dependent) diabetes.

Authors:  I Nosari; G Lepore; M L Maglio; F Cortinovis; G Pagani
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

3.  Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.

Authors:  M Landin-Olsson; K O Nilsson; A Lernmark; G Sundkvist
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

4.  Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.

Authors:  H J Gjessing; L E Matzen; O K Faber; A Frøland
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

5.  Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin.

Authors:  Angus G Jones; Rachel Ej Besser; Beverley M Shields; Timothy J McDonald; Suzy V Hope; Bridget A Knight; Andrew T Hattersley
Journal:  BMC Endocr Disord       Date:  2012-06-08       Impact factor: 2.763

6.  The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.

Authors:  B M Shields; T J McDonald; S Ellard; M J Campbell; C Hyde; A T Hattersley
Journal:  Diabetologia       Date:  2012-01-05       Impact factor: 10.122

7.  Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.

Authors:  Rachel E J Besser; Johnny Ludvigsson; Angus G Jones; Timothy J McDonald; Beverley M Shields; Bridget A Knight; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2011-02-01       Impact factor: 19.112

Review 8.  The clinical utility of C-peptide measurement in the care of patients with diabetes.

Authors:  A G Jones; A T Hattersley
Journal:  Diabet Med       Date:  2013-07       Impact factor: 4.359

9.  Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients.

Authors:  Minoru Iwata; Yumi Matsushita; Kazuhito Fukuda; Tatsurou Wakura; Keisuke Okabe; Yukiko Koshimizu; Yasuo Fukushima; Chikaaki Kobashi; Yu Yamazaki; Hisae Honoki; Hikari Suzuki; Mika Kigawa; Kazuyuki Tobe
Journal:  J Diabetes Investig       Date:  2013-12-26       Impact factor: 4.232

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.